Search results
Results from the WOW.Com Content Network
Frequency. ~25% in any given month [ 7 ][ 8 ] Low back pain or lumbago is a common disorder involving the muscles, nerves, and bones of the back, in between the lower edge of the ribs and the lower fold of the buttocks. Pain can vary from a dull constant ache to a sudden sharp feeling. [ 4 ]
Spinal manipulation appears to provide similar effects to other recommended treatments for chronic low back pain. [57] There is no evidence it is more effective than other therapies or sham, or as an adjunct to other treatments, for acute low back pain [58] "Back school" is an intervention that consists of both education and physical exercises.
Carisoprodol. Carisoprodol, sold under the brand name Soma among others, is a medication used for musculoskeletal pain. [6] Effects generally begin within half an hour and last for up to six hours. [6] It is taken orally (by mouth). [6] Common side effects include headache, dizziness, and sleepiness. [6]
For premium support please call: 800-290-4726 more ways to reach us
Failed back syndrome or post-laminectomy syndrome is a condition characterized by chronic pain following back surgeries. [1] [2] Many factors can contribute to the onset or development of FBS, including residual or recurrent spinal disc herniation, persistent post-operative pressure on a spinal nerve, altered joint mobility, joint hypermobility with instability, scar tissue (), depression ...
While these more serious side effects and drug interactions are rare, it’s important to let your healthcare provider know about any medications or supplements you’re taking before starting ...
Image of visual pain. Pain management is an aspect of medicine and health care involving relief of pain (pain relief, analgesia, pain control) in various dimensions, from acute and simple to chronic and challenging. Most physicians and other health professionals provide some pain control in the normal course of their practice, and for the more ...
Rofecoxib is a COX-2-selective nonsteroidal anti-inflammatory drug (NSAID). It was marketed by Merck & Co. to treat osteoarthritis, rheumatoid arthritis, juvenile rheumatoid arthritis, acute pain conditions, migraine, and dysmenorrhea. Rofecoxib was approved in the US by the US Food and Drug Administration (FDA) in May 1999, and was marketed ...